133 related articles for article (PubMed ID: 6176533)
21. Common epitopes in Clq and collagen type II.
Heinz HP; Rubin K; Laurell AB; Loos M
Mol Immunol; 1989 Feb; 26(2):163-9. PubMed ID: 2465489
[TBL] [Abstract][Full Text] [Related]
22. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
[TBL] [Abstract][Full Text] [Related]
23. [Circulating immune complexes in man; precipitation of immune complexes with polyethylene glycol and their characterization by Clq bound to immunoglobulins].
Grangeot L; Pillot J
C R Acad Hebd Seances Acad Sci D; 1975 Mar; 280(9):1201-3. PubMed ID: 811395
[TBL] [Abstract][Full Text] [Related]
24. Binding and activation of the first complement component by soluble immune complexes: effect of complex size and composition.
Doekes G; van Es LA; Daha MR
Scand J Immunol; 1984 Feb; 19(2):99-110. PubMed ID: 6701474
[TBL] [Abstract][Full Text] [Related]
25. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
[TBL] [Abstract][Full Text] [Related]
26. Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.
Teshima H; Wanebo H; Pinsky C; Day NK
J Clin Invest; 1977 Jun; 59(6):1134-42. PubMed ID: 325016
[TBL] [Abstract][Full Text] [Related]
27. The binding and activation of the Clr-Cls subunit of the first component of human complement.
Hughes-Jones NC; Gorick BD
Mol Immunol; 1982 Sep; 19(9):1105-12. PubMed ID: 6292705
[TBL] [Abstract][Full Text] [Related]
28. The effect of age on the character of immune complex disease: a comparison of the incidence and relative size of materials reactive with Clq in sera of patients with glomerulonephritis and cancer.
Rossen RD; Reisberg MA; Singer D; Suki WN; Duffy J; Hersh EM; Schloeder FX; Hill LL; Eknoyan G
Medicine (Baltimore); 1979 Jan; 58(1):65-79. PubMed ID: 154003
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the soluble immune complexes that are detected by three different techniques.
van der Giessen M; The TH
Clin Immunol Immunopathol; 1986 Feb; 38(2):244-55. PubMed ID: 3484441
[TBL] [Abstract][Full Text] [Related]
30. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
31. Circulating immune complexes in acute schistosomiasis.
Lawley TJ; Ottesen EA; Hiatt RA; Gazze LA
Clin Exp Immunol; 1979 Aug; 37(2):221-7. PubMed ID: 498584
[TBL] [Abstract][Full Text] [Related]
32. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
Schifferli JA; Steiger G; Schapira M
Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288
[TBL] [Abstract][Full Text] [Related]
33. An enzyme-linked immunoassay for circulating immune complexes using solid phased goat Clq.
Lin TM; Halbert SP; Cort R; Blaschke MJ
J Immunol Methods; 1983 Oct; 63(2):187-205. PubMed ID: 6194228
[TBL] [Abstract][Full Text] [Related]
34. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.
O'Sullivan MM; Amos N; Williams BD
Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968
[TBL] [Abstract][Full Text] [Related]
35. Tissue immune complexes demonstrated in the liver of patients with chronic aggressive hepatitis using FITC-labelled human Clq.
Tsuji T; Araki K; Inoue J; Onoue K; Tsuchiya M; Shinohara T; Nagashima H; Nakashima A; Naito K; Arborgh B
Acta Med Okayama; 1980 Jun; 34(3):209-16. PubMed ID: 6447990
[TBL] [Abstract][Full Text] [Related]
36. Immune complexes and abnormal liver function in haemophilia.
McVerry BA; Voke J; Mohammed I; Dormandy KM; Holborow EJ
J Clin Pathol; 1977 Dec; 30(12):1142-6. PubMed ID: 604359
[TBL] [Abstract][Full Text] [Related]
37. Discrepancy between Clq deviation and Raji cell tests in detection of circulating immune complexes in patients with leprosy.
Tung KS; Kim B; Bjorvatn B; Kronvall G; McLaren LC; Williams RC
J Infect Dis; 1977 Aug; 136(2):216-21. PubMed ID: 330768
[TBL] [Abstract][Full Text] [Related]
38. Separation and characterization of complement-fixing immune complexes in juvenile rheumatoid arthritis patients.
Moore TL; Dorner RW
Rheumatol Int; 1986; 6(2):49-52. PubMed ID: 3532285
[TBL] [Abstract][Full Text] [Related]
39. Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients.
Karpatkin S; Nardi MA; Hymes KB
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2263-7. PubMed ID: 7892259
[TBL] [Abstract][Full Text] [Related]
40. Isolation and characterization of intermediate complexes and other components with common antigenic determinants.
Hansson UB; Uesson M; Alkner U
Scand J Immunol; 1981; 13(1):57-66. PubMed ID: 6165073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
